Page last updated: 2024-11-12

n-pentylpantothenamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-pentylpantothenamide: converted to ethyldethia-coenzyme A, an antimetabolite; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10424213
CHEMBL ID447943
SCHEMBL ID17731774
MeSH IDM0445046

Synonyms (7)

Synonym
n5-pan
n-pentylpantothenamide
CHEMBL447943
(2r)-2,4-dihydroxy-3,3-dimethyl-n-[3-oxo-3-(pentylamino)propyl]butanamide
PN4 ,
SCHEMBL17731774
Q27464493
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (2)

PathwayProteinsCompounds
phosphopantothenate biosynthesis I1329
superpathway of coenzyme A biosynthesis I (bacteria)942

Protein Targets (2)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Type II pantothenate kinaseStaphylococcus aureus subsp. aureus MSSA476Km1.50001.50001.50001.5000AID1419201
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1)

Processvia Protein(s)Taxonomy
coenzyme A biosynthetic processPantothenate kinaseEscherichia coli K-12
coenzyme A biosynthetic processPantothenate kinaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
pantothenate kinase activityPantothenate kinaseEscherichia coli K-12
ATP bindingPantothenate kinaseEscherichia coli K-12
kinase activityPantothenate kinaseEscherichia coli K-12
protein homodimerization activityPantothenate kinaseEscherichia coli K-12
pantetheine kinase activityPantothenate kinaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
cytoplasmPantothenate kinaseEscherichia coli K-12
cytoplasmPantothenate kinaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (36)

Assay IDTitleYearJournalArticle
AID409682Antibacterial activity against Escherichia coli K12 in M9 minimal medium after 24 hrs by broth dilution method2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli.
AID511247Inhibition of coenzyme A synthesis in acpH null mutant containing Escherichia coli JT6 transformed with pBAD24 plasmid expressing CoaBC gene assessed as decrease in acetyl CoA level at 100 ug/ml after 90 mins by HPLC relative to untreated control2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID1152961Ratio of kcat to Km for purified Escherichia coli pantothenate kinase by spectrophotometry2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Exploring structural motifs necessary for substrate binding in the active site of Escherichia coli pantothenate kinase.
AID511165Inhibition of coenzyme A synthesis in Escherichia coli JT7 carrying panD deletion assessed as decrease in acetyl CoA level at 100 ug/ml after 90 mins by HPLC relative to untreated control2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID511244Inhibition of coenzyme A synthesis in acpH null mutant containing Escherichia coli JT6 transformed with pBAD24 plasmid expressing CoaA gene assessed as decrease in acetyl CoA level at 100 ug/ml after 90 mins by HPLC relative to untreated control2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID511163Induction of ethyldethia-ACP accumulation in Escherichia coli JT6 at 200 ug/ml by gel electrophoresis2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID593008Antibacterial activity against 10'6 CFU/ml methicillin or oxacillin-resistant Staphylococcus aureus ATCC 43300 after 18 hrs by NCCLS broth microdilution method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
AID409680Activity of Escherichia coli K12 CoaA2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli.
AID1419203Substrate activity at N-terminal His6-tagged Staphylococcus aureus PanK2 expressed in Escherichia coli BL21(DE3) cells assessed as ratio of Kcat to Km in presence of ATP/NADH by pyruvate kinase/lactate dehydrogenase enzyme coupled assay2018Bioorganic & medicinal chemistry, 12-01, Volume: 26, Issue:22
Probing the ligand preferences of the three types of bacterial pantothenate kinase.
AID511167Antibacterial activity against Escherichia coli JT13 expressing in acpH gene assessed as microbial growth inhibition2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID1479610Antibacterial activity against tolC deficient Escherichia coli BW25113 after 20 hrs by broth microdilution method2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria.
AID593014Antibacterial activity against Klebsiella pneumoniae 13883 at 150 ug/ml after 24 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
AID593015Antibacterial activity against Acinetobacter baumannii 19606 at 150 ug/ml after 24 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
AID1479612Antibacterial activity against Escherichia coli ATCC 25922 after 20 hrs by broth microdilution method2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria.
AID760533Antiplasmodial activity against intraerythrocytic Plasmodium falciparum 3D7 infected in human erythrocytes in fresh RPMI-1640 culture medium assessed as parasite growth inhibition after 96 hrs by microscopic analysis2013ACS medicinal chemistry letters, Aug-08, Volume: 4, Issue:8
Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity.
AID593013Antibacterial activity against Staphylococcus aureus 29213 at 150 ug/ml after 24 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
AID511245Inhibition of coenzyme A synthesis in acpH null mutant containing Escherichia coli JT6 transformed with pBAD24 plasmid expressing CoaD gene assessed as decrease in acetyl CoA level at 100 ug/ml after 90 mins by HPLC relative to untreated control2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID1152960Activity of purified Escherichia coli pantothenate kinase by spectrophotometry2014Bioorganic & medicinal chemistry, Jun-15, Volume: 22, Issue:12
Exploring structural motifs necessary for substrate binding in the active site of Escherichia coli pantothenate kinase.
AID409681Ratio of kcat to Km for Escherichia coli K12 CoaA2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli.
AID760532Antiplasmodial activity against intraerythrocytic Plasmodium falciparum 3D7 infected in human erythrocytes in heat treated RPMI-1640 culture medium assessed as parasite growth inhibition after 96 hrs by microscopic analysis2013ACS medicinal chemistry letters, Aug-08, Volume: 4, Issue:8
Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity.
AID409684Antibacterial activity against Escherichia coli K12 in M9 minimal medium after 24 hrs by broth dilution method in presence of pantothenate2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli.
AID1419214Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 hrs by broth microdilution method2018Bioorganic & medicinal chemistry, 12-01, Volume: 26, Issue:22
Probing the ligand preferences of the three types of bacterial pantothenate kinase.
AID511246Inhibition of coenzyme A synthesis in acpH null mutant containing Escherichia coli JT6 transformed with pBAD24 plasmid expressing CoaE gene assessed as decrease in acetyl CoA level at 100 ug/ml after 90 mins by HPLC relative to untreated control2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID511243Antibacterial activity against acpH null mutant containing Escherichia coli JT6 transformed with pJT5 expressing AcpH assessed as microbial growth inhibition2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID409683Antibacterial activity against Escherichia coli K12 in tryptone broth after 24 hrs by broth dilution method2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli.
AID511164Induction of holo-ACP accumulation in Escherichia coli JT6 pJT5 plasmid expressing AcpH at 100 ug/ml after 3 hrs by Western blotting2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID593012Antibacterial activity against Bacillus subtilis 6633 at 150 ug/ml after 24 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
AID1479615Inhibition of Escherichia coli C-terminal His-tagged PPAT expressed in Escherichia coli up to 500 uM using 4'-phosphopantetheine as substrate preincubated for 5 mins followed by substrate and pyrophosphatase addition measured after 30 mins by malachite gr2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria.
AID409685Antibacterial activity against Escherichia coli K12 in M9 minimal medium after 24 hrs by broth dilution method in presence of beta-alanine2008Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coli.
AID593009Antibacterial activity against Escherichia coli 11775 at 150 ug/ml after 24 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
AID593011Antibacterial activity against Bacillus subtilis 6051 at 150 ug/ml after 24 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
AID1419202Substrate activity at N-terminal His6-tagged Staphylococcus aureus PanK2 expressed in Escherichia coli BL21(DE3) cells assessed as Kcat in presence of ATP/NADH by pyruvate kinase/lactate dehydrogenase enzyme coupled assay2018Bioorganic & medicinal chemistry, 12-01, Volume: 26, Issue:22
Probing the ligand preferences of the three types of bacterial pantothenate kinase.
AID511166Antibacterial activity against Escherichia coli JT6 deficient in acpH gene assessed as microbial growth inhibition2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
AID1419201Substrate activity at N-terminal His6-tagged Staphylococcus aureus PanK2 expressed in Escherichia coli BL21(DE3) cells assessed as Km in presence of ATP/NADH by pyruvate kinase/lactate dehydrogenase enzyme coupled assay2018Bioorganic & medicinal chemistry, 12-01, Volume: 26, Issue:22
Probing the ligand preferences of the three types of bacterial pantothenate kinase.
AID593007Antibacterial activity against 10'6 CFU/ml oxacillin-susceptible Staphylococcus aureus ATCC 29213 after 18 hrs by NCCLS broth microdilution method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
AID593010Antibacterial activity against Escherichia coli 25922 at 150 ug/ml after 24 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's8 (72.73)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.20 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]